Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer. (Record no. 21490795)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02318 a2200685 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250516074301.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201202s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1533-4406 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1056/NEJMoa1111065 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | von Minckwitz, Gunter |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20120202 |
| 245 00 - TITLE STATEMENT | |
| Title | Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | The New England journal of medicine |
| Date of publication, distribution, etc. | Jan 2012 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 299-309 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Angiogenesis Inhibitors |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Bevacizumab |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Breast Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cyclophosphamide |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease Progression |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Epirubicin |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Logistic Models |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mastectomy, Segmental |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Medication Adherence |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoadjuvant Therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasm Staging |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Receptor, ErbB-2 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Eidtmann, Holger |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rezai, Mahdi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fasching, Peter A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tesch, Hans |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Eggemann, Holm |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Schrader, Iris |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kittel, Kornelia |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hanusch, Claus |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kreienberg, Rolf |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Solbach, Christine |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gerber, Bernd |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jackisch, Christian |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kunz, Georg |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Blohmer, Jens-Uwe |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Huober, Jens |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hauschild, Maik |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fehm, Tanja |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Müller, Berit Maria |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Denkert, Carsten |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Loibl, Sibylle |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nekljudova, Valentina |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Untch, Michael |
| 773 0# - HOST ITEM ENTRY | |
| Title | The New England journal of medicine |
| Related parts | vol. 366 |
| -- | no. 4 |
| -- | p. 299-309 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1056/NEJMoa1111065">https://doi.org/10.1056/NEJMoa1111065</a> |
| Public note | Available from publisher's website |
No items available.